What was the primary purpose of these offerings?

While the 8-K filing does not explicitly state the purpose, these types of substantial equity and debt offerings are typically undertaken to strengthen the company's capital position, fund growth initiatives, make acquisitions, or meet regulatory capital requirements.

How much capital did MetLife raise from these offerings?

From the common stock offering alone, MetLife raised approximately $3.15 billion (75,000,000 shares * $42.00/share), plus an additional $472.5 million from the underwriters' option exercise (11,250,000 shares * $42.00/share), totaling approximately $3.62 billion. The company also raised $2.75 billion from the fixed-rate senior notes and $250 million from the floating-rate senior notes, for a combined total of approximately $6.62 billion across all offerings.

Who were the underwriters involved in these transactions?

The underwriting syndicate for both the common stock and debt offerings included Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., UBS Securities LLC, and Wells Fargo Securities, LLC, acting as representatives.

What is the significance of these offerings for MetLife's financial structure?

These offerings indicate a strategic move by MetLife to diversify its funding sources and potentially increase its financial flexibility. The significant equity issuance could dilute existing shareholders but strengthens the company's balance sheet. The debt issuances provide long-term financing at varied interest rates, managing the company's cost of capital.

METLIFE INC 8-K SEC Disclosure

Summary

MetLife, Inc. (MET) filed an 8-K report on August 5, 2010, detailing significant capital-raising activities. The company successfully completed a substantial offering of its common stock, selling approximately 86.25 million shares at $42.00 per share, generating significant proceeds for the company. This offering was facilitated through underwriting and pricing agreements with a syndicate of major financial institutions. In addition to the equity offering, MetLife also issued a considerable amount of debt. The company sold $2.75 billion in Fixed Rate Senior Notes across three tranches with maturities in 2014, 2021, and 2041, carrying coupon rates of 2.375%, 4.750%, and 5.875% respectively. Furthermore, MetLife issued $250 million in Floating Rate Senior Notes due 2013. These debt issuances were also conducted under established shelf registration statements and involved a similar syndicate of underwriters.

Key Highlights

1Completion of a significant common stock offering, selling 75,000,000 shares at $42.00 per share, plus an additional 11,250,000 shares due to underwriters' option exercise.
2Total of approximately 86.25 million shares of common stock issued, raising substantial capital.
3Issuance of $1 billion in 2.375% Senior Notes due 2014.
4Issuance of $1 billion in 4.750% Senior Notes due 2021.
5Issuance of $750 million in 5.875% Senior Notes due 2041.
6Issuance of $250 million in Floating Rate Senior Notes due 2013.
7All offerings were conducted under MetLife's existing shelf registration statement (File No. 333-147180) and related prospectus supplements.

METLIFE INC 8-K Report, Corporate Update (Aug 5, 2010)

Summary

Key Highlights

Frequently Asked Questions